Delivery Order SPE2DE21D7009-SPE2D625F2FUM
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $26,980 fixed-price delivery order with economic price adjustment for pain management medical devices by the Medical Supply Chain, a defense-related procurement entity. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, represents a child contract with no set-aside designation. Work will be performed at the contractor's facility in...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $43,829.45 fixed-price delivery order with economic price adjustment for pain management medical devices on September 12, 2025, with an ultimate completion date of September 26, 2025. The contract, which carries no set-aside designation, is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Work will be performed at the contractor's facility in...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, has been awarded a delivery order valued at $43,751.07 for pain management medical devices and services. This fixed-price contract with economic price adjustment, awarded on September 9, 2025, with completion scheduled for September 19, 2025, represents work to be performed at the contractor's facility in Valencia, California. The contract carries no set-aside designation and is funded by the Medical Supply Chain,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $43,829.45 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 16, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace. The contract is funded through the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $1,825.75 for pain management medical devices and services. The contract, awarded on July 31, 2025, with an ultimate completion date of August 25, 2025, utilizes a fixed-price economic price adjustment pricing structure. The work will be performed in Valencia, California, and is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a fixed-price delivery order valued at $31,408.96 for pain management medical devices and equipment. The contract, awarded on July 24, 2025, with an ultimate completion date of July 31, 2025, carries no set-aside designation and will be performed in Valencia, California. The award is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $47,915 fixed-price delivery order with economic price adjustment for pain management medical devices and services. Awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order is issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at $83.1 million through August 16,...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D625F2FUMDelivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $30,564.10 fixed-price delivery order with economic price adjustment on August 29, 2025, for pain management medical devices and services. The contract, which carries no set-aside designation, is set to complete by September 8, 2025, and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract with the Defense Logistics Agency Troop Support Medical branch, valued at approximately $83.1 million through August 2026. The funding agency is the Medical Supply Chain, a defense-related procurement entity supporting federal healthcare operations. Boston Scientific Neuromodulation specializes in non-opioid pain management solutions for service members and veterans, providing advanced neuromodulation technologies including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices. Through the SPE2DE program, the company delivers comprehensive neuromodulation solutions, including proprietary RestoreSensor and Spectra WaveWriter spinal cord stimulators, accessories, training, and technical support to military treatment facilities and Department of Veterans Affairs medical centers nationwide. This delivery order represents continued procurement activity supporting the Department of Defense's pain management initiatives for traumatic injury treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.6k | 8/29/25 |